QSAM Biosciences is a clinical stage company developing effective therapeutic radiopharmaceuticals for bone cancer & bone marrow ablation
Location: United States, Texas, Austin
Employees: 1-10
Founded date: 2004
Investors 1
| Date | Name | Website |
| - | Checkmate ... | checkmatec... |
Mentions in press and media 2
| Date | Title | Description |
| 14.11.2023 | QSAM Biosciences Signs Term Sheet to be Acquired by Telix Pharmaceuticals; Receives $2 Million Pre-Closing Collaboration and Option Fee | - |
| 10.03.2023 | QSAM Biosciences Receives Clearance from FDA to Expand Enrollment Criteria in its Phase 1 Study of CycloSam Targeting Metastatic Bone Cancer | QSAM Biosciences, a company developing next generation therapeutic radiopharmaceuticals, including Samarium-153-DOTMP (CycloSam), for the treatment of bone cancer and related diseases and conditions, announces that the U.S. Food & Drug ... |